Comment on “PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer”
The recently published study by Zang et al. offers valuable insight into PSMA-PET/CTbased response assessment in patients with oligometastatic prostate cancer (PCa) undergoing stereotactic ablative body radiotherapy (SABR), demonstrating an impressive 5-year local control rate of 86 % and progressiv...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2025-11-01
|
| Seri Bilgileri: | Clinical and Translational Radiation Oncology |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2405630825001235 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|